Selenium for Sperm Quality

Selenium is genuinely required for sperm production - but the trials that made its reputation were mostly done in men who were deficient, and that context is usually dropped in marketing.

Randomised trials, particularly a widely cited study combining selenium with N-acetylcysteine in infertile men, report improved sperm concentration, motility and morphology over several months. Selenium is structurally essential to sperm: the mitochondrial capsule of the midpiece is built partly from a selenoprotein, so deficiency produces sperm with broken or bent tails. The caveat is important. Benefit is clearest where status is low, and one large trial of antioxidant supplementation in men with normal nutritional status found no improvement in pregnancy rates. Selenium fixes a deficiency; it does not upgrade already-adequate fertility.

Spermatogenesis is exceptionally vulnerable to oxidative damage: sperm membranes are rich in polyunsaturated fatty acids, the cells carry almost no cytoplasmic antioxidant machinery, and their DNA is tightly packed and poorly repaired. Reactive oxygen species from leukocytes, varicocele, smoking or heat cause lipid peroxidation and DNA fragmentation.

Selenium acts through selenoproteins. Glutathione peroxidase 4 is the dominant one in testis, doubling as an antioxidant enzyme and, in oxidised form, as the structural protein of the mitochondrial capsule surrounding the sperm midpiece. Selenoprotein P delivers selenium to the testis, and knockout models show severe spermatogenic failure. This dual role - antioxidant and structural - is why selenium deficiency causes distinctive motility defects rather than a general reduction in count.

Doses sit close to the nutritional requirement, and the therapeutic window is narrow.

There are currently no studies linked to this pairing in our library, so no study list is shown.

Randomised trials in infertile men report improved sperm concentration, motility and morphology with selenium, most convincingly in combination with N-acetylcysteine, and the selenoprotein biology gives an unusually specific mechanistic account. Observational work consistently links low selenium status to poor semen parameters. Against this: most trials are small, conducted in populations with low baseline selenium, and measure semen parameters rather than live birth. The large MOXI trial of antioxidant therapy in men with normal status found no benefit for pregnancy or live birth, and Cochrane reviews of antioxidants for male subfertility describe the evidence as low quality with considerable uncertainty.

Selenium at 100-200 micrograms daily is well tolerated by most people. The distance between adequate and excessive is unusually small, so cumulative intake from all sources needs attention.

Male infertility deserves proper evaluation rather than supplement-led self-management: varicocele, hormonal disorders, infection, obstruction and genetic causes are all treatable or important to identify, and testicular cancer occasionally presents this way. A couple who have not conceived after twelve months, or six months if the female partner is over 35, should seek assessment.

Stacked selenium sources and competing fertility factors are the practical issues.

No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.